Report Categories
View AllRecent Articles
View All
Perdoceo PRDO Q4 revenue surges 24 yearoveryear to 846M EPS beats estimates by 7
WU Western posts steep Q1 2026 EPS miss against analyst estimates notches small 045 percent gain today
HTOO Fusion posts blowout Q4 2021 EPS beat but shares drop 153 percent in todays session
The macro factors Stoke Therapeutics STOK discussed in earnings Q4 2025 Profit Disappoints